# EDGAR Filing Document

**Accession Number:** 0001816389
**File Stem:** 0001193125-25-203777
**Filing Date:** 2025-9
**Character Count:** 9261
**Document Hash:** 47c92bf14f6b18c2ded302015832d99f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-203777.hdr.sgml**: 20250915

**ACCESSION NUMBER**: 0001193125-25-203777

**CONFORMED SUBMISSION TYPE**: SC TO-I/A

**PUBLIC DOCUMENT COUNT**: 12

**FILED AS OF DATE**: 20250915

**DATE AS OF CHANGE**: 20250915

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BlackRock Private Investments Fund
- **CENTRAL INDEX KEY:** 0001816389

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94022
- **FILM NUMBER:** 251315077

**BUSINESS ADDRESS:**
- **STREET 1:** 100 BELLVIEW PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809
- **BUSINESS PHONE:** 800 882 0052

**MAIL ADDRESS:**
- **STREET 1:** 100 BELLVIEW PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BlackRock Private Investments Fund
- **CENTRAL INDEX KEY:** 0001816389

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A

**BUSINESS ADDRESS:**
- **STREET 1:** 100 BELLVIEW PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809
- **BUSINESS PHONE:** 800 882 0052

**MAIL ADDRESS:**
- **STREET 1:** 100 BELLVIEW PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

**SCHEDULE TO** 

**TENDER OFFER STATEMENT** 

**Under Section 14(d)(1) or 13(e)(1)** 

**of the Securities Exchange Act of 1934** 

**(Amendment No. 1)** 

## BlackRock Private Investments Fund
**(Name of Subject Company (Issuer))** 

**(Names of Filing Person(s) (Issuer))** 

**Common Shares of Beneficial Interest, Par Value $0.001 per Share** 

**(Title of Class of Securities)** 

**Institutional Shares – 09260N105** 

**Class D Shares – 09260N303** 

**Class S Shares – 09260N402** 

**Class T Shares – 09260N501** 

**(CUSIP Number of Class of Securities)** 

**John M. Perlowski** 

**BlackRock Private Investments Fund** 

**50 Hudson Yards** 

**New York, New York 10001** 

**(800) 882-0052** 

**(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Person(s))** 

***Copies to:***

---

| | |
|:---|:---|
| **Margery K. Neale, Esq.**<br> **P. Jay Spinola, Esq.**<br> **Willkie Farr & Gallagher LLP**<br> **787 Seventh Avenue**<br> **New York, New York 10019** | **Janey Ahn, Esq.**<br> **BlackRock Advisors, LLC**<br> **50 Hudson Yards**<br> **New York, New York 10001** |

---

**April 30, 2025** 

**(Date Tender Offer First Published, Sent or Given to Security Holders)** 

☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which this statement relates:

☐ third-party tender offer subject to Rule 14d-1

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ issuer tender offer subject to Rule 13e-4

☐ going-private transaction subject to Rule 13e-3

☐ amendment to Schedule 13D under Rule 13d-2

Check the following box if the filing is a final amendment reporting the results of the tender offer. ☒

------

This Amendment No. 1 (this "Final Amendment") relates to the Issuer Tender Offer Statement on Schedule TO originally filed on April 30, 2025 (the "Schedule TO"), by BlackRock Private Investments Fund, a Delaware statutory trust (the "Trust"), pursuant to Rule 13e-4 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), in connection with an offer by the Trust (the "Offer") to purchase up to 5% of its issued and outstanding common shares of beneficial interest, par value $0.001 per share (including Institutional, Class D, Class S and Class T common shares, the "Shares"), as of March 31, 2025, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated April 30, 2025 (the "Offer to Purchase"), and in the related Letter of Transmittal, copies of which were previously filed as Exhibits (a)(1)(i) and (a)(1)(ii), respectively, to the Schedule TO.

This is the Final Amendment to the Schedule TO and is being filed to report the results of the Offer. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Offer to Purchase or the Schedule TO.

The following information is furnished pursuant to Rule 13e-4(c)(4) under the Exchange Act:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Offer expired at 11:59 p.m., Eastern time, on May 28, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The Offer was undersubscribed. Therefore, in accordance with the terms of the Offer, the Trust purchased Shares
from all tendering shareholders. 391,107.533 Institutional Shares of the Trust were validly tendered and not withdrawn prior to the expiration of the Offer, and all of those Shares were accepted for repurchase by the Trust in accordance with the
terms of the Offer. No Class D Shares, Class S Shares or Class T Shares of the Trust were tendered and not withdrawn prior to the expiration of the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The Valuation Date of the Shares tendered pursuant to the Offer was June 30, 2025. The NAV per
Institutional Share on the Valuation Date was $12.86. The NAV per Class D Share on the Valuation Date was $12.73. There were no Class S Shares or Class T Shares outstanding on the Valuation Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Payment of the repurchase price was made in the form of a promissory note issued to each shareholder whose
tendered Shares were accepted for repurchase by the Trust. On July 30, 2025, in accordance with the terms of the Offer and the promissory notes, the Trust paid such shareholders of the Trust $4,824,046.04, collectively, of the cumulative amount
payable under the promissory notes, and the remaining $205,596.85 was paid on September 12, 2025 (in each case net of any applicable early repurchase fee).

In addition, (i) Item 3 of the Schedule TO is hereby amended to reflect that, effective July 1, 2025, the Investment Advisor is a majority-owned subsidiary of BlackRock, Inc., and (ii) Items 3 and 5 of the Schedule TO are hereby amended to reflect that BlackRock International Limited, an affiliate of the Trust and the Investment Advisor, has been appointed to serve as a sub-adviser to the Trust. Except for the foregoing or as otherwise specifically provided herein, the information contained in the Schedule TO, as amended, and the Letter of Transmittal remains unchanged and this Final Amendment does not modify any of the information previously reported in the Schedule TO, as amended, or the Letter of Transmittal.

---

| | |
|:---|:---|
| **Item 12(b).** | **Filing Fees**  |

---

[Filing Fee Exhibit is filed herewith.](d875791dexfilingfees.htm)

------

**SIGNATURE** 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| | |
|:---|:---|
| **BlackRock Private Investments Fund** | **BlackRock Private Investments Fund** |
| By: | /s/ John M. Perlowski |
|  | Name: John M. Perlowski |
|  | Title: President and Chief Executive Officer |
|  | Dated: September 15, 2025 |

---

------

**<u>Exhibit Index</u>**

---

| |
|:---|
| Exhibit |
| [Filing Fee Exhibit](d875791dexfilingfees.htm) |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

 **Calculation of Filing Fee Tables** <br>

---

| | | | |
|:---|:---|:---|:---|
| | | **Transaction Valuation**  | **Amount of Filing Fee**  |
| Fees to be Paid |  |  |  |
| Fees Previously Paid | 1 | $15627351.05 | $2392.55 |
|  | Total Transaction Valuation: | $15627351.05  |  |
|  | Total Fees Due for Filing: |  | $2392.55  |
|  | Total Fees Previously Paid:  |  | $2392.55  |
|  | Total Fee Offsets:  |  | $0.00  |
|  | Net Fee Due:  |  | $0.00  |

---

 **Offering Note** <br>

<sup>1</sup> The transaction value is calculated as the aggregate maximum purchase price for Shares that could be purchased, based upon the net asset value of the Trust as of March 31, 2025. The fee of $2,392.55 was paid in connection with the filing of the Schedule TO-I by BlackRock Private Investments Fund (File No. 005-94022) on April 30, 2025 (the "Schedule TO"). This is the final amendment to the Schedule TO and is being filed to report the results of the offer. The amount of filing fee is calculated at $153.10 per $1,000,000 of the transaction valuation in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, as modified by Fee Rate Advisory No. 1 for fiscal year 2025.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Fee Paid with Fee Offset Source |
| Fee Offset Claims | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Fee Offset Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |

---